Medical Misinformation: Vet the Message! by Hill, Joseph A et al.
Medical Misinformation: Vet the Message!
Undoubtedly, the majority of cardiologists have had conversations just
like this, urging a patient to take a statin, powerful cholesterol-lowering
drugs with robust mortality benefit. Part of the reason these often-
times ‘no brainer’ recommendations are rejected derives from widely
disseminated incorrect information which vastly over-states the risks
of these drugs. (Of course, like anything in life, statin use is not entirely
risk-free; their application should always entail a thoughtful analysis of
risks vs. benefits.) Most patients do not recognize that the benefits of
statin use are invisible (‘I didn’t have a heart attack or stroke this past
year’.), whereas the small and typically reversible risks (e.g. muscle
pain) are readily apparent. Many patients who would benefit from sta-
tin use do not take them.
Cardiovascular disease is the no. 1 killer of both men and women
around the world. Robust scientific advances, published in the pages of
our journals, have fostered significant improvements that benefit indi-
viduals and society. Yet, cardiovascular disease continues to transform
itself, emerging in new forms, such as heart failure. The struggle has
shifted to new battlefields.
These successes derive from an armamentarium of powerful
tools—medicines and devices—and awareness of lifestyle-related haz-
ards, such as high blood pressure, high cholesterol, and smoking. Sadly,
however, we do not take full advantage of the tools at our disposal.
One significant cause of suboptimal utilization of our prodigious
tool chest is medical misinformation hyped through the internet, tele-
vision, chat rooms, and social media. In many instances, celebrities, acti-
vists, and politicians convey false information; not uncommonly,
authors with purely venal motives participate.
We can point to numerous other examples, including the entirely
unfounded concerns regarding vaccinations. The notion MMR (mea-
sles, mumps, rubella) vaccination causes autism was based on a sin-
gle, flawed study, long since refuted, and its publication retracted.
Seventeen much larger and properly controlled studies have proven
otherwise. Nevertheless, the internet shouts unfounded warnings.
Once again, celebrities, actors, activists, and politicians with no spe-
cific knowledge or training use their fame to promote a message
that causes serious harm. Individuals who are neither physicians nor
scientists, but often with a specific agenda, have outsized influence
over our lives. They dispute scientific evidence without ever having
studied it.1
Recognizing that it is impossible to prove ‘never’, scientists appropri-
ately couch their statements in statistical terms, which may come
across to the public as equivocation. The nuanced voices of scientists
often do not resonate with the public as much as the strident alarms
sounded by people of fame, speaking in absolute terms.
Further, scientists are appropriately sceptical, because any individual
scientist or study can be wrong. Yet, science ultimately self-corrects.
When a scientist gets it wrong, as happens, people sometimes vilify the
entire, self-correcting scientific enterprise. We trust aeronautical sci-
ence when we board an aeroplane; we trust the science buried within
our cell phones; we trust mechanical engineering science when we
cross a bridge; yet, many are uniquely sceptical of biological science.
Sadly, we cannot exclude that some in the professions of science
and medicine act based on motives driven by financial considerations;
incomplete declarations of potential conflict of interest persist.2
Recent examples of dramatic price hikes for important medications
have reinforced this notion. Indeed, many physicians have had conver-
sations with patients who believe that our recommendations stem, at
least in part, from the prospect of personal financial gain.
We, the editors-in-chief of the major cardiovascular scientific jour-
nals around the globe, sound the alarm that human lives are at stake.
Pointing to the two examples elaborated above, people who decline
to use a statin when recommended by their doctor, or parents who
withhold vaccines from their children, put lives in harm’s way.
The media must do a better job. It is unacceptable to posit false
equivalents in these discussions, often done to foster debate and con-
troversy. It is easy to find a rogue voice but inappropriate to suggest
that voice carries the same weight as that emerging from mainstream
science. (We can easily point to examples outside the medical domain,
as well, such as climate change, evolution, nutraceuticals, and GMO
foods where false equivalents are frequently posited.) Furthermore,
recent evidence suggests that misinformation travels faster through
social networks than truth.3 We must work to enhance science liter-
acy in our world; one place to start is by doing a better job of teaching
the scientific method in our schools so that the lay public is aware that
science is accomplished in fits and starts, but in the end, gets it right.
Purveyors of social media must be responsible for the content they
disseminate. It is no longer acceptable to hide behind the cloak of
‘platform’. We, as editors, are charged with evaluating the validity of
‘Mrs Jones, based on your risk factors for having a heart attack, I recommend that we start you on a statin’.
‘No, thank you, doctor, I’ve read too many scary things about those drugs on the internet. Plus, I worry that some in your profession make
these recommendations for reasons of personal financial gain. I also found that online’.
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the science presented to us for possible publication, and we work hard
to fulfil this heady responsibility. Recognizing that lives are at stake, we
reach out to thought-leading experts to evaluate the veracity of each
report we receive. Here, we challenge social media to do the same, to
leverage the ready availability of science-conversant expertise before
disseminating content that may not be reliable.
Without exaggeration, significant harm, to society and individuals,
derives from the wanton spread of medical misinformation. It is high
time that this stop, and we lay at the feet of the purveyors of internet
and social media content the responsibility to fix this.
A complete list of all journals publishing this article, along with links
to the individual articles, can be found online at https://www.ahajour
nals.org/circ/medical-misinformation.
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